Advertisements
Year

Inturrisi, Charles

Relmada Therapeutics, Inc., United States

2022 Rank: 245949

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Pharmacology & Pharmacy

SubField 2:

Neurology & Neurosurgery

Rank in SubField 1: 1991 out of 134745 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score245949254735
Total Cites262287
H-index77
Hm-index34
Number of Single Authored Papers1414
Total Cites to Single Authored Papers66
Number of Single+First Authored Papers4242
Total Cites to Single+First Authored Papers3434
Number of Single+First+Last Authored Papers180180
Total Cites to Single+First+Last Authored Papers131139
Composite Score22
Number of Distinct Citing Papers227240
Ratio of Total Citations to Distinct Citing Papers 1.15 1.20
Self-Citation Percentage
8.71%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements